James Hutchinson Profile
James Hutchinson

@James_Hutc

Followers
53
Following
66
Media
7
Statuses
109

Regensburg, Germany
Joined June 2013
Don't wanna be here? Send us removal request.
@cp_humphries
Chris Humphries
1 year
Our trial protocol is out - first-in-human allogeneic macrophages for the treatment of paracetamol liver injury. Can they fill the gap between acetylcysteine and transplant? https://t.co/iLdzuEy0zb @EdinClinTox
bmjopen.bmj.com
Introduction Acute liver failure (ALF) has no effective treatment other than liver transplantation and is commonly caused by paracetamol overdose. New treatments are needed to treat and prevent ALF....
0
2
0
@eballestar
Esteban Ballestar
1 year
Don't miss our collaborative study proposing combined therapy for #MultipleSclerosis Targeting #AhR w/ #DMF restores #tolerogenic #DendriticCells properties | A basis for new clinical trials @FedericoFonde @Eva_M_C @GTRecerca @CarrerasIJC @hgermanstrias https://t.co/eMHGkMTxbs
1
10
34
@James_Hutc
James Hutchinson
1 year
First Class Doctorate for Federico! ⁦@INsTRuCT_h2020
0
0
1
@James_Hutc
James Hutchinson
1 year
The August issue of Transplantation picked-up Dataset Restriction as a Research Highlight. Find the full article by Collin Z Jordan at
Tweet card summary image
journals.lww.com
An abstract is unavailable.
0
2
2
@James_Hutc
James Hutchinson
2 years
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients - eBioMedicine
thelancet.com
Overall, our data indicate that combining Treg cell therapy with CKBMT dampens the alloimmune response to transplanted kidneys in humans in the absence of myelosuppression.
0
0
1
@James_Hutc
James Hutchinson
2 years
0
0
0
@TransplantJrnl
Transplantation
2 years
Social media and scientific publishing. Why it's important for authors and readers to follow articles from Transplantation and Transplantation Direct. Our editor @BaanCarla explains!
0
8
19
@James_Hutc
James Hutchinson
2 years
Restriction also helps with intraclass heterogeneity. An unanticipated consequence of restriction is that disease biomarkers with a bimodal distribution in the positive class, such as might arise from multiple aetiologies, are findable. #biomarkers #predictive_models #ROC_curve
1
1
3
@James_Hutc
James Hutchinson
2 years
Applying restriction as a pre-processing step typically improves the performance of multivariate models.
1
1
1
@James_Hutc
James Hutchinson
2 years
Restriction is a procedure that splits datasets into classifiable and unclassifiable samples to define a biomarker’s informative and uninformative ranges.
1
1
2
@James_Hutc
James Hutchinson
2 years
Our new paper in Nat Comms tackles the special challenge of unequal variability between classes for immune biomarker discovery and interpretation. We introduce Dataset Restriction as a solution that can be extended to any classification task. https://t.co/RSfD5PlM3r
Tweet card summary image
nature.com
Nature Communications - Immune disease-associated biomarker values are commonly more variable in affected compared to unaffected patient populations, which limits a biomarker’s informative...
1
2
3
@James_Hutc
James Hutchinson
2 years
Health implies homeostasis, whereas disease means dysregulation. It shouldn’t surprise us that disease markers are often more variably expressed in patients than controls @ExtraHorizon_ @INsTRuCT_h2020 @GGlehr @die_paloma #melanoma #irAE
1
2
4
@James_Hutc
James Hutchinson
2 years
IL-4+ iNKT cells are a mechanistically surprising subset in hepatic steatosis that certainly deserve more attention. Congratulations to Florian, Paul, Raphael and Giulia!
@die_paloma
Paloma Riquelme
2 years
Promising new marker of early liver disease that links hepatocyte stress in fatty liver disease with iNKT cell activation in patients with MASLD: Soluble CD46 as a diagnostic marker of hepatic steatosis
0
0
2
@James_Hutc
James Hutchinson
2 years
Congratulations Maria for graduating Cum Laude! @INsTRuCT_h2020 👩🏻‍🎓
0
0
1
@James_Hutc
James Hutchinson
3 years
Immune profiling of adipose tissue lymphocytes from patients with peritoneal carcinomatosis undergoing CRS-HIPEC leads to interesting new hypotheses. Good job, Julia!
link.springer.com
Cancer Immunology, Immunotherapy - Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment option for peritoneal carcinomatosis (PC) from...
0
0
3
@James_Hutc
James Hutchinson
3 years
New article by Florian and Jordi - well done. Case report: Predictability of clinical response and rejection risk after immune checkpoint inhibition in liver transplantation
0
0
1
@Mar_mies
María Iglesias
3 years
The Extra project is looking for PhD candidates: ✅If you are willing to relocate to Barcelona ✅Have a background in translational Immunology & flow cytometry ✅ Are interested in the field of solid organ transplantation Please check out the link (workpack DoC9) @Inmunocanruti
1
8
10
@James_Hutc
James Hutchinson
3 years
exTra is a spin-off from INsTRuCT focused on apoptotic cell therapy in solid organ transplantation. If you’re looking for a PhD project with translational relevance, apply to exTra before 15th August, 2023.
@INsTRuCT_h2020
INsTRuCT
3 years
exTra opened a call for 11 MSCA PhD Student positions to train in Basic and Translational Immunology. Projects in DE, AT, UK, NL and ES. Apply through EURAXESS.
0
2
4